| Sl.No | Name of the Scholar | Name of the Supervisor | Title | Year of Completion |
| 1 | Dr. P. VALENTINA | Dr K Ilango | Synthesis, Biological Activities And Qsar Studies Of 3, 6-Disubstituted-1, 1,2, 4-Triazolo-[3, 4-B]-1, 3, 4 -Thiadiazole Analogues | May – 2011 |
| 2 | Dr. THIRUMALA RAJESH | Dr. K.S. Lakshmi | Development And Validation Of Liquid Chromatographic Methods For The Quantification Of Anti-Diabetic Drugs In Formulations And Biological Samples | June – 2011 |
| 3 | Dr. V. CHITRA | Dr K Ilango | A Prospective Phytochemical And Pharmacological Screening Of Fruit Pulp Of Limonia Acidissima Linn | June – 2011 |
| 4 | Dr. LAKSHMI SIVASUBRAMANIAN | Dr. K.S. Lakshmi | Development And Validation Of Analytical Techniques For Quantitative Estimation Of Some Antihypertensive Drugs | June – 2011 |
| 5 | Dr. R. VADIVU | Dr. K.S. Lakshmi | Pharmacognostical, Phytochemical And Pharmacological Evaluation Of The Leaves Of Symplocos Cochinchinensis (Lour.) ,  S.Moore Ssp.Laurina (Retz.) Nooteb. (Symplocaceae) | September – 2011 |
| 6 | Dr. S. ARUNKUMAR | Dr K Ilango | Synthesis, Characterization, Pharmacological Screening And Qsar Analysis Of Novel Gallic Acid Derivatives | October – 2011 |
| 7 | Dr. SRINIVAS SHARMA | Dr. K.S. Lakshmi | Impact Of Age Inhibitors On The Morphological And Biochemical Aspects Of Experimental Cataract: An In Vitro And In Vivo Study | February – 2012 |
| 8 | Dr. M. MOTHILAL | Dr. K.S. Lakshmi | Optimization Of Sustained Release Bilayer Floating Tablets Of Diltiazem Hydrochloride Using Factorial Design | August – 2012 |
| 9 | Dr. M.G. RAJANANDH | Dr K Ilango | Assessment of Various Second Line Treatment Regimens on Mild to Moderate Persistent Asthmatic Patients | February – 2015 |
| 10 | Dr.N. KASTHURI BAI | Dr K Ilango | Comparative pharmacognostical phytochemical In vitro screening of antioxidant and antidiabetic activities of Monochoria species | October – 2015 |
| 11 | Dr. P.G. SUNITHA | Dr K Ilango | Assessment of Various Second Line Treatment Regimens on Mild to Moderate Persistent Asthmatic Patients | April – 2015 |
| 12 | Dr. T.M. VIJAYAKUMAR | Dr K Ilango | Assessment of Various Second Line Treatment Regimens on Mild to Moderate Persistent Asthmatic Patients | September – 2015 |
| 13 | Dr. K. ANANTHA KUMAR | Dr K Ilango | A Study on the Pharmacokinetics and Pharmacodynamic Properties of Major Bioactive Compounds Present in Polyherbal Formulations | April – 2016 |
| 14 | Dr. INAMPUDI JYOTHI | Dr K Ilango | Assessment of Neuropsycho pharmacological, Action of Polyherbal Formulation in Association with Regulation of Biomarkers and Sleep Pattern in Mild to Moderate Depressed Patients | August – 2016 |
| 15 | Dr.V. MANIMARAN | Dr. N. Damodharan | Development of fast dissolving tablets of calcium channel blockers using solid dispersion technology | July – 2018 |
| 16 | Dr.K. MANIKANDAN | Dr. K.S. Lakshmi | Method development and validation of analytical techniques for the quantification of selected drug combinations in pharmaceutical formulations using chemometric tools. | August – 2018 |
| 17 | Dr. J. KAVITHA | Dr. K.S. Lakshmi | Development And Validation Of Analytical Methods For The Quantification Of Additives In Cosmetics And Personal Care Products | November – 2018 |
| 18 | Dr.V.J. VISHNU VARATHAN | Dr. K.S. Lakshmi | Evaluation,Identification and comparison on therapeutic effect of formononetin and formononetin loaded solid lipid nanoparticles in the treatment of lung carcinoma | May – 2019 |
| 19 | Dr. A.PORSELVI | Dr. M.S. Uma Shankar | Design development and implementation of clinical pharmacist intervened effective programme for the management and prevention of diabetic foot ulcer | May – 2019 |
| 20 | Dr. J. NARAYANAN | Dr. V. Chitra | Neuropharmacological exploration of Garcinia hanburyi and its isolated compounds on diabetes related AlzheimerÂs disease | May – 2019 |
| 21 | Dr. S.P. SURYA TEJA | Dr. N. Damodharan | Design and Optimization of Tumor Targeted Ph Responsive Chitosan Nanoparticles using Quality by Design Approach | July – 2020 |
| 22 | Dr. G. POOVI | Dr. N. Damodharan | Surface-modified long-circulating biocompatible nanostructured lipid carrier for the poorly water-soluble drug | August 2020 |
| 23 | Dr. R. KAVITHA | Dr. N. Damodharan | Optimization of Medium Components and Process Parameters for Enhanced Production of Prodigiosin by Doe Approach and Its Activity on Retinoblastoma Cells | November – 2020 |
| 24 | Dr. P.N. REMYA | Dr. N. Damodharan | An Experimental Study on Photoplethysmography PPG Signal With Respect to Age and Cardiac Abnormality Detection | November – 2020 |
| 25 | Dr. SRIKALYANI VEMURI | Dr K Ilango | Chemometric Approach for the Multiple Response Optimization of Phytomarkers and Pharmacokinetic Assessment of Berberine in Manasamitra Vatakam: An Ayurvedic Herbomineral Formulation | February – 2021 |
| 26 | Dr. K. MANASA | Dr. V. Chitra | Neuroprotective role of camalexin in aldehyde dehydrogenase mediated benomyl induced parkinsonÂs disease in zebrafish and animal models | April – 2021 |
| 27 | Dr. S. NANDHINI | Dr K Ilango | Comparative pharmacognostical and phytochemical analysis of adhatoda species and development of phytosome formulation using adhatoda vasica to enhance vasicine bioavailability | June – 2021 |
| 28 | Dr. A. BHARATH KUMAR | Dr. M.S. Uma Shankar | Impact of Clinical Pharmacist care In the prevention and management of Atherosclerotic Cardiovascular Disease in Diabetic Patients | September – 2021 |
| 29 | Dr. EVELYN SHARON .S | Dr. V. Chitra | Alleviation of Postmenopausal Osteoporosis by Phytoestrogenic Isoflavones from Kiwi And Mangustan In Experimental Animal Models | September – 2021 |
| 30 | Dr. SARVESH | Dr. T.M. Vijayakumar | Cyp3a4 Mediated Pharmacokinetic Drug Interaction Potential Of Maha Yogaraj Gugglu Tablet And E, Z-Guggulsterone | February – 2022 |
| 31 | Dr. K SHALINI | Dr K Ilango | Pharmacognostical And Phytochemical Studies Of Selected Indian Medicinal Plants For The Development Of Polyherbal Formulation And Preclinical Evaluation Of Mitigating The Symptoms Of Polycystic Ovarian Syndrome | March – 2022 |
| 32 | Dr.D. JAISON | Dr. M. Mothilal | Development of magnetic nanocomposites and other nano-pharmaceuticals for cancer theranostics | March – 2022 |
| 33 | Dr. D. PRIYA | Dr. M.K. Kathiravan | Design, Synthesis And Evaluation Of Novel 1, 5-Diaryl Pyrazole Derivatives As Cancer Associated Selective Cox-2 Inhibitors | April – 2022 |
| 34 | Dr. K.S. KOKILAMBIGAI | Dr. K.S. Lakshmi | Development and Validation of Analytical methods for selected drugs and combinations using Quality By Design and Green Chemistry Approach | April – 2022 |
| 35 | Dr. RAVULA SATHITHYA RAVALI R | Dr. K.S. Lakshmi | Pharmacognostical And Phytochemical Studies Of Selected Indian Medicinal Plants For The Development Of Polyherbal Formulation And Preclinical Evaluation Of Mitigating The Symptoms Of Polycystic Ovarian Syndrome | April – 2022 |
| 36 | Dr..B. SHANTHAKUMAR | Dr. M.K. Kathiravan | Development of magnetic nanocomposites and other nano-pharmaceuticals for cancer theranostics | August – 2022 |
| 37 | Dr. R. SEETHARAMAN | Dr. K.S. Lakshmi | Design, Synthesis And Evaluation Of Novel 1, 5-Diaryl Pyrazole Derivatives As Cancer Associated Selective Cox-2 Inhibitors | August – 2022 |
| 38 | Dr. CHANDULURU HEMANTH KUMAR | Dr. S. Abimanyu | Development and Validation of Analytical methods for selected drugs and combinations using Quality By Design and Green Chemistry Approach | September – 2022 |
| 39 | Dr. KANNAIAH KANAKA PARVATHI | Dr. S. Abimanyu | Environmentally Benign Method Development And Validation Of Creams And Ointments Using Uv Spectrophotometry And Aqbd Based Lc Methods | September – 2022 |
| 40 | Dr. T.S. SARASWATHI | Dr.M. Mothilal | Optimization And Characterization Of Nasal Niosomal In-Situ Gel For The Treatment Of Brain Ailments | November – 2022 |
| 41 | Dr. M.B. RAHUL REDDY | Dr. M.K. Kathiravan | Design, Synthesis And Evaluation Of Hybrid Heterocyclic Derivatives Against Mycobacterium Tuberculosis | November – 2022 |
| 42 | Dr. S. SAKTHI PRIYADARSINI | Dr.P.R. Kumar | Chemotherapeutic Potential Of Luisia Tenuifolia Blume Whole Plant Extracts And Its Isolated Coumarin Compounds Against Skin Cancer ÂÂ A Pharmacognostical, Phytochemical And Pharmacological Study | December – 2022 |
| 43 | Dr. P. GOPINATH | Dr. M.K. Kathiravan | Design And Development Of Novel Substituted Benzenesulfonamides As Human Carbonic Anhydrase Ix Inhibitors | December – 2022 |
| 44 | Dr. MUTHKURU MAYURI | Dr. T.M. Vijayakumar | In-silico, in-vitro and in-vivo evaluation of nk1r antagonist 17-trifluromethyl phenyl prostaglandin-f2 in the treatment of breast cancer | February – 2023 |
| 45 | Dr. R. SRIMATHI | Dr. M.K. Kathiravan | Design, synthesis and evaluation of coumarin and chromene analogs for breast cancer | March – 2023 |
| 46 | Dr. MANASRANJAN SAHOO | Dr. Umashankar | Development and evaluation of herbal based lozenges formulations | March – 2023 |
| 47 | Dr. VARA PRASAD SAKA | Dr. N. Damodharan | Neurodegenerative and behavioural changes in weaning rodents induced by exposure of mobile phone radiation and screening for neuroprotection of hispolon derivatives | September – 2023 |
| 48 | Dr. H. GAYATHRI | Dr. S. Sangeetha | Formulation development of anticancer drug loaded transferosomes for the treatment of skin cancer | September – 2023 |
| 49 | Dr. ANIL KUMAR YERRAGOPU | Dr. V. Chitra | Enhancement of anti-tumor immune response by targeting immunogenic cell death in carcinogen and cell-line induced tumor models of mice | September – 2023 |
| 50 | Dr. G.V. NARASIMHA KUMAR | Dr. V. Chitra | Pharmacological evaluation of marine phlorotannin rich fraction of sargassum tenerrimum in high fat diet and streptozotocin induced type ii diabetic rats | September – 2023 |
| 51 | Dr. G.V. ANJANA | Dr. M.K. Kathiravan | Synthesis and evaluation of deuterated derivatives as antimicrobial agents | September – 2023 |
| 52 | Dr. K. GOWRI | Dr. V. Chitra | Ameliorative effect of collagenase induced osteoarthritis in diabetic sprague dawley rat model by the phytosterols of durio zibethinus linn | September – 2023 |
| 53 | Dr. V. SHARMILA DEVI | Dr. M. Sumithra | Phytochemical Standardization and Pharmacological Evaluation of Polyherbal Formulation for the Treatment of Diabetic Nephropathy | March – 2024 |
| 54 | Dr. MURALI KRISHNA MOKKA | Dr. M. Sumithra | study of hydroalcoholic extract and alkaloid rich fraction of tinospora cardifolia stems against continuous light induced polycystic ovarian syndrome on rodent model | March – 2024 |
| 55 | Dr.SWARNA BHARATHI KALLI | Dr. V. Velmurugan | Design, Synthesis and Biological Evaluation of DPP-4 Inhibitors against Type-2 Diabetes Mellitus | April – 2024 |
| 56 | Dr. NANDIMANDALAM SAI SUPRA SIDDHU | Dr. T.M. Vijayakumar | Safety and efficacy of A Novel Polyherbal Extracts combination in the management of Osteoarthritis. | April – 2024 |
| 57 | Dr. ANKUL SINGH S | Dr. V. Chitra | Neuroprotective effect of Luffa cylindrica (LINN.) Fruit against Ozone-induced Neuronal damage in Experimental Animal model | April – 2024 |
| 58 | Dr. KOLA HEPHZIBAH | Dr. S. Sangeetha | QbD Assisted Analytical Method For Quantifying Candesartan Cilexetil – Pioglitazone Simultaneously in Formulated Solid Dispersion Dual Release Bilayer Tablet | April – 2024 |
| 59 | Dr. RUKAIAH FATMA BEGUM | Dr. M. Sumithra | Preclinical and Clinical evaluation of Vitamin E Add-on Therapy with Fourth Generation on CombinedOral Contraceptive Pill against Polycystic Ovarian Syndrome | May 2024 |
Menu
